Maloff Protect is indicated for the chemoprophylaxis of plasmodium falciparum (P. Falciparum) malaria in adults and contains two active ingredients: atovaquone and proguanil hydrochloride.
The film-coated tablets should be taken daily from one to two days before travel to a malaria-affected area continue during the period of the stay and for a further seven days after leaving the area. The 250mg/100mg tablets are available through pharmacy, without a prescription, over-the-counter or online for eligible adults.
Being able to sell Maloff Protect directly to customers presents pharmacies with the opportunity to provide an extended service for adults aged 18 and over, traveling to malaria-endemic countries.
Maloff Protect 24 Tablets
PIP Code | 4028650
Trade Price £31.43
RRP ex VAT £39.99
Pharmacy Margin 21%
Pharmacy Margin £8.56
Maloff Protect 36 Tablets
PIP Code | 4028668
Trade Price £47.15
RRP ex VAT £58.50
Pharmacy Margin 19%
Pharmacy Margin £11.35
Supply classification: P
Maloff Protect Summary Document and Patient Information will both be available on the Learning Room.
GLENMARK PHARMACEUTICAL EUROPE LTD
Glenmark is an innovation‐driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses. It focuses on the key therapeutic areas of respiratory, dermatology and oncology. The company has 10 world‐class manufacturing facilities spread across 4 continents and operations in over 80 countries.
PP-UK-MLF-0402
October 2023
Cookies
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
